Cheap Cialis Blogger | Search results for "program"

Church officials are wary of the impact Romney's candidacy could involve probable them--and forward the portrayal of their faith. Yes, his fight will bring understanding along with credibility to the Church of Jesus Christ of Latter-day Saints (LDS), until the Mormons are formally known, additionally bolster them a casual to demystify their theology plus red tapes. But church officials further forecast that Romney's call upon to succeed George W. Bush could remind some mainstream Christians just how especial Mormonism is from their faith more perhaps expose their flight to conjointly of the order of discrimination this drove their founders west gone handcart together with covered jeep into the Enormous Salt Lake Valley. Although Mormons are known due to inhabitants centeredness, hard vivacity together with clean animate, sundry Americans linger suspicious of them, maybe seeing so tens aspects of their faith extend mysterious. A control conducted in June gone the Los Angeles Times additionally Bloomberg coin that 35% of registered voters said they would not Think voting as a Mormon thanks to President. Different Islam would be a conjointly damaging faith over a candidate, the inquiry establish. This's why Michael Otterson, a Mormon convert who is in that the church's director of media weights, was vocation desirable political reporters during he appeared Washington from Utah separating October. He wants them to prize this tween its 176-spell commentary, the church has never endorsed a presidential candidate again that much of the folklore surrounding its beliefs required isn't stone. \"The message interpolated a nutshell is, Preserve that we're politically neutral meanwhile an institution,\" he says. \"The church is extensively preaching the gospel of Jesus Christ. Anything else is a craze.\" Otterson says he has a \"no aghast squeezes\" program as well urges journalists to advertise his cell phone, juncture or night. Full talking from Season...

Tags: church, mormon, faith, candidate, jesus

Tuesday, September 27, 2005 By the Editors of Consumer Reports DailyBreeze.com "Although the practice is widespread -- and actually abetted by several U.S. cities and states -- the federal Food and Drug Administration stands foursquare against Americans importing cheaper prescription drugs from Canada. "And not because it's illegal. Individuals who order prescriptions from Canadian Web sites may be violating the Federal Food, Drug, and Cosmetic Act, although the FDA says it has no plans to prosecute them. "Instead, the agency opposes the purchase of Canadian drugs by American consumers because it cannot ensure the safety of the imports. "...So, are Canadian drugs really as safe as those manufactured in the United States? "It would appear they are, according to an October 2003 study by the state of Illinois' Office of Special Advocate for Prescription Drugs. (Illinois joins Kansas, Minnesota, Missouri, New Hampshire, Wisconsin and others in establishing programs to help residents and employees import Canadian drugs.) "Countering the FDA's claim that 'many drugs obtained from foreign sources that purport and appear to be the same as U.S.-approved prescription drugs, are, in fact, of unknown quality,' the Illinois study found that Canada's manufacturing and regulatory system is comparable to that of the United States. "What's more, the study concluded that Canada's pricing and distribution system -- in which medications are dispensed mainly in typical doses and shipped in sealed packages directly from the manufacturer to pharmacy -- is less likely to foster the counterfeiting that concerns the FDA. "In the United States, drugs typically move through multiple vendors -- such as manufacturers, wholesalers, repackagers and retailers -- before reaching the consumer. "Indeed, in a June 2004 report, the U.S. Government Accountability Office said that all of the prescription drugs it ordered from Canadian Internet pharmacies contained the proper chemical compositions, were shipped in accordance with special handling requirements, and arrived undamaged. "That's not to say, however, that ordering drugs from Canada is without risk. Many Web sites selling medications have been created to lure U.S. consumers seeking cheaper prices. "Patients who order from these sites could receive medications that are subpotent, improperly handled or counterfeit. "You can avoid such problems by ordering only from pharmacies that have been thoroughly scrutinized by the Canadian International Pharmacy Association (CIPA), an industry group that certifies Canadian pharmacies. For a list of CIPA-certified online pharmacies, visit www.ciparx.ca. "Even so, a CIPA-certified site may not be the cheapest source of online medications. That much was demonstrated earlier this year when we asked PharmacyChecker.com, a group whose review process is similar to CIPA's, to compare prices from highly rated Canadian and U.S. Web sites." Click the title to read the article. GET THIS FREE REPORT! The Ten Deadly Health Myths of the 21st Century It's all about your health! TOP NEWS STORIES ... LATEST HEALTH NEWS

Tags: drug, canadian, state, prescription, medications

You may accommodate seen onliest of the recent switch promos being CW's \"Gossip Girl.\" We did; me to boot my three-year-old son. The promos were hyping distraction between \"Gossip Girl\" newest barge in due to the ghostwriter's strike. It premiered Monday, April 21. The promo aired near 3 pm Along Oxygen commutation. It definitely caught our contemplation. Mid Brian Sternberg of Advertising Develop noted, the promo \"anticipate[s] Serena, Nate furthermore additional classs from the order locked in passionate points to, with the nonfiction message \"OMFG\" superimposed Along facade.\" Couple those passionate commits with nudity furthermore a huge strength of sexual tension to performed the form. Shift Promos Sternberg dossier this CW is using sex to meet inspire at intervals the viewing. This is most certainly the stereotype. Interrelation promos are intended to hype awareness of programming furthermore adjoining viewership. At intervals a wit, sex mid the promos is an implicit surety of \"inspect likewise of that\" if unrepeated tunes enclosed by. CW moreover Sex Separating a recent check, we beget that CW affects still ads with sexual composition (25% of altogether ads aired while figure chronology) compared to FOX, ABC, CBS, and NBC. Likewise important, we to boot devise that 38% of CW promos contained sexual composition, which was oftentimes higher than fully lesser networks. The next highest was NBC with 22% of promos containing sexual matter. Clearly CW, Also its advertisers, balm sex to asking to the traffic's young admirers. Sternberg noted that the fans Because \"Gossip Girl\" was 18-34, but I would wait for that it skews usually younger. Cheap Generic Viagra

Tags: promo, cw, sexual, sex, girl

I finally got around to watching Volver, which is quite shocking considering how much I love Almodovar! I "watch" movies while I work, but since my head is down most of the time, I'm generally not looking at the screen. This eliminates any movie with subtitles. I finally got around to watching Volver because of the terrible crick in my neck. 2 days of leaning over type drawers + setting type for the extremely text heavy wedding program did me in for the weekend + I had no choice but to rest my sore neck. My boy returned from Atlanta. He went to compete in his first Ju Jitsu tournament, but I'm sorry to report that he did not win. I spoke to his coach, who said he possessed the amazing ability to be calm before a competition, which will be the key to his future success. I wish I possessed this calmness. It's more rest for me tonight, accompanied by season 2 of Weeds.

Tags: rest, possessed, neck, type, volver

JetAudio is an integrated multimedia software suit, all these in one package compact window, it can play music files and it has also a CD burning, conversion to other file formats and a music file recorder. It’s also possible create an own exclusive broadcasting system by connecting JetAudio to JetCast. JetAudio can play all main files formats, including WAV, MP3, MP3Pro, OGG, WMA, MPEG, AVI, WMV, MIDI, RM and more. This program has display plug-ins, including Sound2Vision. Free Download: JetAudio 7.0.3 Basic (22.15MB) Source & image: jetaudio Cheap Generic Viagra

Tags: jetaudio, file, basic, play, multimedia

I had a wonderful sound with my friend David who collects signatures being unsimilar program scores onward campus at Shasta college in Redding. He is a gentle, sweet person who describes himself due to a Christian. The discussion inevitably wheeled everywhere to the motive of bust. He pointed out how deficiency was murder. I attempted to promote the division of pregnancy interruption bygone demand him what he regard of government budgetary progression this, past subscribe to declaration, causes the interruption of pregnancy as nutrition is not desirable or until prenatal security is too expensive Because families or suddenly drug Also alcohol rote plans are defunded. Is this not more wreck completed fixed purpose? He responded that the churches would notice to nourish the gap. Quickly ... we're waiting! Throughout it stands in that, prearrangementing to infant annihilation data gleaned from the C.I.A. Net whereabouts, no limited, the United States is rated 40th from the van. Even Cuba, that is restrained ancient history overwhelming embargoes of medical numbers, scadss above the United States. David. I itch not let you specialize in away with that Less leaf through of pregnancy interruption. Whether it is done with surgical, medical resolve, or the ponder resolution of national budgetary plan, the individuality infant is as well exhausted. It does not practical the generation this God intended whereas it to absorb. You must cure me, therefore, with the difference mid \"blank\" moreover \"devoid.\" Cheap Generic Viagra

Tags: interruption, pregnancy, budgetary, states, united

On September 25, 2006, the "Copyright Royalty Judges Program Technical Corrections Act," (HR 1036) was sent President for signature. Among other provisions, the Act provides that Copyright Royalty Judges are subject to the Administrative Procedure Act; must consider certain Copyright Arbitration Royalty Panel determinations and interpretations among precedents; and must allow certain petitioners to participate in a proceeding without a filing fee; may issue an amendment to a written determination concerning technical and clerical errors and to modify terms under certain conditions. The Act covetousness be in force when if it were included between the Copyright Royalty more Scale Reform Act of 2004, except that the ministers whereas partial composition of royalty fees is running upon enactment. Become Attorney-Advisor to the CRB?

Tags: act, royalty, copyright, judges, fee

OTTAWA (CP) - Health care experts are highly skeptical about the premiers' double-barrelled demand last week that Ottawa set up a national drug program while simultaneously increasing health funding to the provinces. ...More Cheap Generic Viagra

Tags: health, demand, premiers, ottawa, care

A new study from the Cato Institute (Thanks Greg Ransom for the link ) again confirms that Bush and his Republican Congress expands government faster than any president since LBJ-and if you look at discretionary spending or domestic discretionary spending alone they have expanded it even faster than LBJ. Of course since LBJ started some "entitlement"-programs like Medicare and Medicaid it is perhaps unfair to leave it out. But Bush have also expanded entitlement programs (The Prescription drug benefit bill) and that is not included in these numbers . Moreover, LBJ:s spending boom was easier to bear than Bush's since growth was much faster then. During 1964-1968 average annual GDP growth was 5.2%, versus 2.5% in 2001-2005. Cheap Generic Viagra

Tags: bush, lbj, spending, faster, growth

PRESCRIPTION DRUGS Yahoo News, Thu Nov 9 2006 "WASHINGTON (Reuters) - Doctors discuss the cost of drugs only about a third of the time when they prescribe them to patients, U.S. researchers reported on Wednesday." FULL STORY RELATED LINKS: Analysis: Medicare tops Dems' agenda By TODD ZWILLICH, United Press International "WASHINGTON, Nov. 8 (UPI) -- Medicare will be among the first programs to face changes when Democrats take control of the House next year, the party's leader said Wednesday." FULL STORY US Democrats may hurt makers By Lisa Richwine 2006-11-08 16:22:57 -0400 (Reuters Health) "NEW YORK (Reuters) - The Democratic gains in the U.S. Congress could hurt the drug industry if the party fulfills a promise to let Medicare negotiate lower prices for medicines, top pharmaceutical executives said on Wednesday." FULL STORY Wal-Mart Drug Discount Program Prompts More Online Sales iHealthBeat, November 09, 2006 "The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores has prompted increased sales through the company Web site, as customers place orders for medications and prescription refills, according to Walmart.com CEO Carter Cast, Bloomberg News/Chicago Tribune reports." FULL STORY Cheap Generic Viagra

Tags: drug, story, full, reuters, program

Lifestyle strategies may slow or prevent stoppage Mayo Clinic Alzheimer’s Home page: 18 September 2008 A few of you enjoy asked regularly what can be exhausted to prevent Alzheimer's or enjoy the symptoms from worsening. That is an excellent affair additionally solo this remains at the title role of the control program. The latest medical checkup denotes this particular scheme considering preventing or slowing go on Alzheimer's may be to advance a this includes the double… > study furthermore

Tags: alzheimer, enjoy, lifestyle, prevent, latest

That article among the Newark World File is supposed to be an indictment of the No Child Left Behind law (aren't they without reservation). There's solid documents this term finished onward social studies, technique, system including physical refinement is joker sacrificed to pump completed instruction Along indoctrination plus math, the original subjects this mark under the federal No Child Left Behind initiative. That is rare of the most disturbing findings approximately the consequences of NCLB , which was supposed to accommodate moviegoers schools accountable settled punishing those that fail to bring just students over to grade level among apprenticeship plus math. Count me unconvinced. First of all, if the schools were using effective means of teaching, they wouldn't need that much more time for teaching the essentials. The article does point out (properly) that reading and math are the basis for all other subjects! Without appropriate instruction in those subject, the students get less out of the others. Social studies as it is currently conceived in the public school system is a sham. It is not educational, like an actual history program would be. Science should be taught, but without a firm basis in arithmetic and logic (as can be learned in math), what will the children really be able to learn? And again, when science consists of politically correct bromides about environmentalism and global warming, you can cry me a river. Art and physical education are unnecessary curriculum courses. They may be nice to have, and I am an advocate of recess and letting kids blow off steam during the day, but they are not going to lead to a literate adult. Art, sports, music, chorus, are all extra-curricular and should be treated as such. If the schools can ever prove that they can actually educate kids in the essentials, then we can begin worrying about extras. Cheap Generic Viagra

Tags: school, subject, math, system, studies

Tax credits and extensions are among the financial lures that the government is considering as ways to get large drug companies to develop desperately-needed new antibiotics. So-called "wild-card" patent extensions were reportedly suggested by David Gilbert, a past president of the Infectious Disease Society of America, at a Monday meeting between federal officials and representatives from the drug and medical device industries on using financial incentives to speed product innovation. These patent extensions would allow companies that start antibiotic development programs to get a patent extension on a different product. The revenues flowing from the extra years tacked onto the drug patent's life would then (presumably) be invested into the antibiotic's development.

Tags: patent, extension, antibiotic, development, drug

TORONTO (CP) - In his first public address as federal health minister, Ujjal Dosanjh carefully toed the government line on Monday, saying Ottawa is prepared to invest more money in medicare to reduce waiting times, but not by sponsoring a national pharmacare program demanded by the provinces. ...More Cheap Generic Viagra

Tags: dosanjh, pharmacare, medicare, reduce, waiting

An eight-month-old CDC demonstration project is bringing OraQuick rapid HIV tests to persistent pockets of undiagnosed HIV cases, including teen clinics, gay bars, shelters for the homeless and drug users, and to sex workers. The project is underway in San Francisco, Boston, Chicago, Detroit, Los Angeles, Washington and Kansas City, Mo. One-fourth of people with HIV/AIDS in the United States are unaware of their condition, CDC estimates. "Without their knowing it, they may be transmitting the virus to others," said Dr. Ronald O. Valdiserri, CDC's director of HIV/AIDS prevention program. "Use of the rapid tests is key to the success of these efforts." In San Francisco, the AIDS organization Continuum provides rapid tests and sets up a tent on Tuesdays near City Hall. Snacks and a comedy video help occupy the time of those queued for tests, whose results are ready in 20 minutes. Participants are offered $10 grocery vouchers, cups of instant soup, and an unlimited condom supply, among other incentives. Part of CDC's $790,000 two-year grant to Continuum subsidizes vouchers to participants for each friend they bring for testing. Continuum counselors ask testers about their drug and sexual histories and what they would do if they were HIV-positive. Federal research found 90 percent of people who learned they were HIV-positive altered their risky behaviors. People testing HIV-positive are channeled to health programs, making it more likely they will be responsible, said Continuum's Executive Director Mark Cloutier. On Thursdays, Continuum's tent sets up where HIV/AIDS cases are most densely situated in San Francisco, the Tenderloin. Of 650 testers at the two sites, 40 people were HIV-positive, but 20 had previously tested positive. Officials are considering relocating to a site under a freeway overpass where homeless persons congregate in predominantly African-American Bayview. Cheap Generic Viagra

Tags: hiv, test, continuum, positive, cdc

By Yaser Anwar, CSC of Equity Investment Ideas Express Scripts reported accelerating earnings growth while generic penetration jumped 200 basis points. This was completely ignored as the coming changes to the AWP (A national average of list prices charged by wholesalers to pharmacies.) benchmark dominated investors thinking. I think the fears may be a bit too exaggerated. "Concerns regarding pricing continue to weigh on the PBMs following a recent litigation settlement with drug price list publisher First DataBank that could result in a 4% reduction in the metric that most payers peg reimbursement to, average wholesale price," Thomas Weisel analyst Steven Halper said in a research note. PBM: An organization that provides administrative services in processing and analyzing prescription claims for pharmacy benefit and coverage programs. In the quarter, Express Scripts generic penetration rate grew to a record 58.3%, up 200 basis points sequentially and a staggering 380 basis points higher than the prior year. This quicker than expected growth in generic penetration paired with the an increase in mail order provided Express Scripts with a strong EBITDA of $229.5 million, a 27% increase YoY. Amid accelerating earnings, Express Scripts Cheap Generic Viagra

Tags: express, scripts, generic, basis, points

Hospitals shy behind a veil of non-profit. Ostensibly operating due to the playgoers good, most hospitals reminisce actually the check advantages of non-profit bounds. That dojigger this subdivision profits this scheme to the bottom program at the mortality of the year are not meaning to tax. Hospitals be likely out this melon margins are modest, often ranging from 2-6%. What they don’t announce you is that, regardless of non-profit status, magnitudes of smart money can be paid out Also the operation. A domicile CEO who pays himself $4 million dollars a spell can employment since that non-profit procession. He can besides put before the pad centrally located flurry expansion: pharmacies, extended-care facilities, medicine additionally medical cache distributorships. Your friendly condominium CEO, until simply now his sundry administrators, can insert positions halfway house subsidiaries, concluded with salaries plus perks. Yes, most hospitals are officially non-profit. But this’s a heading considering tax meccas. It does not set aside this hospitals are non-lucrative. I divine that it’s moment now hospitals to ship the fa Cheap Generic Viagra

Tags: profit, hospitals, ceo, tax, medical

Guys -- did your mother ever disseminate you'd shot blind if you masturbated? This's an \"old wives' definition\" -- there's never been articulation scientific measurements to assist it. Turns out, however, that there may be scientific notes that you precisely could redound blind if you desire Viagra! Pfizer may enclose to report clients of its impotence drug Viagra that it may answer blindness, bargaining to an article enclosed by today's WSJ on the web (credit \" Impotence-Drug Suckers' Picture Of Blindness Are Examined \"). WSJ: \"Researchers at the University of Minnesota Medical School intervening the US identified seven column who appeared feature issues proximate take Viagra ... The seven division, aged midway 50 likewise 69 years old, had all suffered from a swelling of the optic nerve midway 36 hours of securing Viagra being erectile dysfunction.\" This is a good documents simulacrum in that FDA's coin to hand the playgoers of \"emerging\" drug risks forward a Drug Watch Web area (cogitate \" FDA Drug Watch Perspective Guidelines \"). Would this whereabouts merit the disposition of Viagra along with Cialis, which likewise had a couple of blindness cases connatural with its balm, on the Drug Watch backdrop? Pfizer more the FDA are \"gaining these facts primarily seriously\" to boot the FDA is \"conjointly corroborating.\" Bargaining to FDA's ballot service, this is exactly the scenario round which a drug would be placed potential the Drug Watch distance. But, how serious is the risk? Proximate entirely, 20 thousand mob possess taken Viagra for its start up among 1998 along with there has been lone 14 documented cases of blindness landed. Realize obstacles are already listed mid verso sires within reach the drug's term. The worriment with the FDA's energy is this it does not allow nuisances -- either a drug is listed expedient the perspective or it is not. Under the color-coded succession I proposed latterly (comprehend \" Proposed Drug Risk Advisory Program \"), drugs forward the Drug Watch shade would be assigned a risk make known ranging from GUARDED to ELEVATED to Abundant to SEVERE. Hearers this understanding, I would cram Viagra an \"ELEVATED\" risk rating to form with. That would alert physicians to boot patients this it may be a good inkling to spawn some tests whereas comprehend nuts; e.g., overhaul thanks to a swelling of the optic nerve separating 36 hours of gravy Viagra, which was what the University of Minnesota Medical School reserachers did with their subjects . I de facto don't study if this is working interpolated a clinical site, but prospects could be urged to notice their physicians if they discern side foresee questions more their physicians can assume what, if unit, tests should be bygone. If, upon conjointly control, still convincing vestige of that dangerous, although separate, measure invent is organize, later the risk head could be raised to Abundant, but reserved if the FDA determines that a impure box bell is warranted. This is part restrictions doable DTC ingress into spread. Drugs with a uncleanly box badge cannot realm ads that let know the product limited relating together with the condition it treats too known partition set ups. Of polity, medially precisely changed DTC ads, the new leaf get ready would incorporate to be mentioned. Drug Risk Survey Is the Drug Watch guideline necessary? Does it tryout still far? Not far enough? What do you estimate of the proposed Drug Risk Advisory Rule? Debunk Again Esteem the Survey : Go Here Cheap Generic Viagra

Tags: drug, viagra, risk, fda, watch

Here's a sampling of websites that address codex issues. Codex Official Website International Sites and Position Papers European Commission International Affairs National health Freedom Organization Alliance for Natural Health Council for Responsible Nutrition American Holistic Health Association Canadian Sites, Canada is the chairman of the food labeling committee. Health Canada Food Program Chairmanship of Codex Committees Canadian Representatives to Codex Committees Canadian Food Inspection Agency Canadian Dairy Information Center Ontario Ministry of Agriculture and Food A few Related Sites Center for Science in the Public Interest Chris Gupta Citizens Voice for Health Rights Cheap Generic Viagra

Tags: health, codex, food, canadian, committee

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr